← All stocks

Kiniksa Pharmaceuticals International, plc

KNSA Mostly scheduled
CIK 0001730430 #1216 in the set updated 17 Sep 2026
Bought (12 mo)
$0.00
out of their own pocket, the only kind of buying there is
Sold (12 mo)
$61.90M
$1.38M on a plan · $60.22M straight out of an exercise
Sold at will
$299.09K
1 of 48 sales
Net
−$61.90M
−$299.09K against sales at will

By person

13 insiders · 49 transactions
Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
Patel Sanj K
CHAIRMAN & CEO
$39.43M (12) scheduled
−$39.43M
1,205,731
1.6%
$96.82M
+436.0%
Paolini John F.
CHIEF MEDICAL OFFICER
$8.00M (6) scheduled
−$8.00M
69,922
0.090%
$5.61M
+34.4%
Ragosa Mark
CHIEF FINANCIAL OFFICER
$5.56M (8) scheduled
−$5.56M
20,854
0.027%
$1.67M
−29.4%
Tessari Eben
CHIEF STRATEGY OFFICER
$3.10M (7) scheduled
−$3.10M
23,130
0.030%
$1.86M
−81.4%
Quart Barry D
Director
$2.68M (8) scheduled
−$2.68M
12,745
0.016%
$1.02M
+36.0%
Megna Michael R
CHIEF ACCOUNTING OFFICER
$2.64M (4) scheduled
−$2.64M
29,062
0.037%
$2.33M
+9.9%
Cole G Bradley
Director
$299.09K (1)
−$299.09K
7,172
0.009%
$575.91K
−23.5%
Moat Ross
CHIEF OPERATING OFFICER
$194.50K (2) scheduled
−$194.50K
16,307
0.021%
$1.31M
−25.0%
BAKER BROS. ADVISORS LP entity
Director
2,744,894
3.5%
$220.41M
+1.4%
Levy Richard S
Director
22,359
0.029%
$1.80M
+73.4%
Popovits Kimberly J
Director
15,345
0.020%
$1.23M
+63.7%
McCain Tracey L
Director
15,345
0.020%
$1.23M
+63.7%
Malley Thomas
Director
15,345
0.020%
$1.23M
+63.7%
Insider
Date
Role
Action
Shares
Price
Amount
Cole G Bradley
29 Jul 2026
Director
Sell
3,673
$81.43
$299.09K

What was left out

Form 4 filings counted 59
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 1
Sales on a Rule 10b5-1 plan 5
Sales straight out of an exercise 42
Sales at will 1
Transactions with no price 0
Shares from compensation/vesting 2,812,984
History held since 29 May 2018